UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Caractéristiques sociodémographiques et cliniques de patients souffrant de troubles bipolaires suivis en ambulatoire en France métropolitaine

Encéphale, 2012-06, Vol.38 (3), p.211-223

2012

Volltextzugriff (PDF)

Pratiques thérapeutiques dans la prise en charge des patients souffrant de troubles bipolaires en France. Étude TEMPPO

Encéphale, 2012-02, Vol.38 (1), p.75-85

2012

Volltextzugriff (PDF)

Évaluation de la consommation d’alcool et du score au GHQ-28 chez 486 avocats du barreau de Paris

Encéphale, 2007-12, Vol.33 (6), p.990-991

2007

Volltextzugriff (PDF)

Évolution de l’autonomie sociale chez des patients schizophrènes selon les prises en charge. L’étude ESPASS

Encéphale, 2010-10, Vol.36 (5), p.397-407

2010

Volltextzugriff (PDF)

Caractéristiques psychométriques de la version française de la signs and symptoms of psychotic illness scale (SSPI)

Encéphale, 2007-10, Vol.33 (5), p.744-750

2007

Volltextzugriff (PDF)

2288 – A 12-week, randomized, placebo-controlled study evaluating the efficacy and safety of aripiprazole in combination with lithium/valproate inpartially-responsive bipolar mania

European psychiatry, 2013, Vol.28, p.1-1

2013

Volltextzugriff (PDF)

P01-226-Line item analysis in paediatric patients with bipolar I disorder treated with aripiprazole

European psychiatry, 2011, Vol.26 (S2), p.227-227

2011

Volltextzugriff (PDF)

P01-317 - Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric patients: Results from a 52-week open-label study

European psychiatry, 2011, Vol.26, p.319-319

2011

Volltextzugriff (PDF)

P01-38 - Efficacy of adjunctive aripiprazole in patients with major depressive disorder: pooled analysis of subgroup data from three clinical trials

European psychiatry, 2010, Vol.25 (S1), p.258-258, Article 25-E257

2010

Volltextzugriff (PDF)

PW01-20 - Adjunctive aripiprazole in patients with major depressive disorder: pooled safety and tolerability data from three short-term studies

European psychiatry, 2010, Vol.25 (S1), p.1438-1438, Article 25-E1422

2010

Volltextzugriff (PDF)

P01-39 - Adjunctive aripiprazole in patients with major depressive disorder: efficacy data from three short-term studies

European psychiatry, 2010, Vol.25 (S1), p.259-259, Article 25-E258

2010

Volltextzugriff (PDF)

P01-57 - Analysis of pooled safety data from three randomized, double-blind, placebo-controlled studies of adjunctive aripiprazole in major depressive disorder

European psychiatry, 2010, Vol.25 (S1), p.278-278, Article 25-E276

2010

Volltextzugriff (PDF)

P02-35 - Effect of adjunctive aripiprazole in achieving various levels of response and on domains of functioning in MDD: A pooled analysis

European psychiatry, 2011, Vol.26, p.630-630

2011

Volltextzugriff (PDF)

PW01-36 - The long-term safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar I patients partially non-responsive to mood stabilisers

European psychiatry, 2010, Vol.25 (S1), p.1455-1455, Article 25-E1438

2010

Volltextzugriff (PDF)

PW01-60 - Similar short- and long-term efficacy results of aripiprazole in post-pubertal adolescents (ages 15-17) and adults with schizophrenia

European psychiatry, 2010, Vol.25 (S1), p.1476-1476, Article 25-E1459

2010

Volltextzugriff (PDF)

P03-182 A 16-week, multicentre, randomized, open-label study assessing effects of aripiprazole versus other atypicals for schizophrenia patients with metabolic syndrome

European psychiatry, 2009, Vol.24, p.S1181-S1181

2009

Volltextzugriff (PDF)

PW01-11 - Effect of adjunctive aripiprazole on quality of life in patients with major depressive disorder: pooled data from three clinical trials

European psychiatry, 2010, Vol.25 (S1), p.1427-1427, Article 25-E1413

2010

Volltextzugriff (PDF)

P03-19 Evaluation of dyslipidaemia risk among patients treated with aripiprazole: Meta analysis of placebo- and olanzapine-controlled studies

European psychiatry, 2009, Vol.24, p.S1018-S1018

2009

Volltextzugriff (PDF)

P01-58 - Adjunctive aripiprazole in patients with major depressive disorder: pooled data on functioning from three clinical trials

European psychiatry, 2010, Vol.25 (S1), p.279-279, Article 25-E277

2010

Volltextzugriff (PDF)

Mortalité par cancer et schizophrénie : suivi de cohorte de 11 ans

Revue d'épidémiologie et de santé publique, 2009-05, Vol.57, p.S57-S57

2009

Volltextzugriff (PDF)

Erratum to “Clozapine treatment of a borderline personality disorder with severe self-mutilating behaviours”

European psychiatry, 2004-09, Vol.19 (6), p.393-393

2004

Volltextzugriff (PDF)

Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric patients: Results from a 52-week open-label study

European psychiatry, 2011-03, Vol.26 (S2), p.319-319

2011

Volltextzugriff (PDF)

Effect of adjunctive aripiprazole in achieving various levels of response and on domains of functioning in MDD: A pooled analysis

European psychiatry, 2011-03, Vol.26 (S2), p.630-630

2011

Volltextzugriff (PDF)

A 16-week, Multicentre, Randomized, Open-label Study Assessing Effects of Aripiprazole Versus other Atypicals for Schizophrenia Patients with Metabolic Syndrome

European psychiatry, 2009-01, Vol.24 (S1), Article 24-E1181

2009

Volltextzugriff (PDF)

Evaluation of Dyslipidaemia Risk among Patients Treated with Aripiprazole: Meta Analysis of Placebo- and Olanzapine-controlled Studies

European psychiatry, 2009-01, Vol.24 (S1), Article 24-E1018

2009

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Französisch
(52)
Englisch
(26)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Caractéristiques sociodémographiques et cliniques de patients souffrant de troubles bipolaires suivis en ambulatoire en France métropolitaine

Pratiques thérapeutiques dans la prise en charge des patients souffrant de troubles bipolaires en France. Étude TEMPPO

Évaluation de la consommation d’alcool et du score au GHQ-28 chez 486 avocats du barreau de Paris

Évolution de l’autonomie sociale chez des patients schizophrènes selon les prises en charge. L’étude ESPASS

Caractéristiques psychométriques de la version française de la signs and symptoms of psychotic illness scale (SSPI)

2288 – A 12-week, randomized, placebo-controlled study evaluating the efficacy and safety of aripiprazole in combination with lithium/valproate inpartially-responsive bipolar mania

P01-226-Line item analysis in paediatric patients with bipolar I disorder treated with aripiprazole

P01-317 - Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric patients: Results from a 52-week open-label study

P01-38 - Efficacy of adjunctive aripiprazole in patients with major depressive disorder: pooled analysis of subgroup data from three clinical trials

PW01-20 - Adjunctive aripiprazole in patients with major depressive disorder: pooled safety and tolerability data from three short-term studies

P01-39 - Adjunctive aripiprazole in patients with major depressive disorder: efficacy data from three short-term studies

P01-57 - Analysis of pooled safety data from three randomized, double-blind, placebo-controlled studies of adjunctive aripiprazole in major depressive disorder

P02-35 - Effect of adjunctive aripiprazole in achieving various levels of response and on domains of functioning in MDD: A pooled analysis

PW01-36 - The long-term safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar I patients partially non-responsive to mood stabilisers

PW01-60 - Similar short- and long-term efficacy results of aripiprazole in post-pubertal adolescents (ages 15-17) and adults with schizophrenia

P03-182 A 16-week, multicentre, randomized, open-label study assessing effects of aripiprazole versus other atypicals for schizophrenia patients with metabolic syndrome

PW01-11 - Effect of adjunctive aripiprazole on quality of life in patients with major depressive disorder: pooled data from three clinical trials

P03-19 Evaluation of dyslipidaemia risk among patients treated with aripiprazole: Meta analysis of placebo- and olanzapine-controlled studies

P01-58 - Adjunctive aripiprazole in patients with major depressive disorder: pooled data on functioning from three clinical trials

Mortalité par cancer et schizophrénie : suivi de cohorte de 11 ans

Erratum to “Clozapine treatment of a borderline personality disorder with severe self-mutilating behaviours”

Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric patients: Results from a 52-week open-label study

Effect of adjunctive aripiprazole in achieving various levels of response and on domains of functioning in MDD: A pooled analysis

A 16-week, Multicentre, Randomized, Open-label Study Assessing Effects of Aripiprazole Versus other Atypicals for Schizophrenia Patients with Metabolic Syndrome

Evaluation of Dyslipidaemia Risk among Patients Treated with Aripiprazole: Meta Analysis of Placebo- and Olanzapine-controlled Studies

Aktive Filter

Suchergebnisse filtern